Ignite Creation Date:
2025-12-25 @ 4:49 AM
Ignite Modification Date:
2025-12-26 @ 3:50 AM
Study NCT ID:
NCT04214418
Status:
TERMINATED
Last Update Posted:
2024-12-18
First Post:
2019-12-27
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Combination Therapy With the MEK Inhibitor, Cobimetinib, Immune Checkpoint Blockade, Atezolizumab, and the AUTOphagy Inhibitor, Hydroxychloroquine in KRAS-mutated Advanced Malignancies
Sponsor:
Columbia University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-02-12
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-01
Completion Date Type:
ACTUAL
First Submit Date:
2019-12-27
First Submit QC Date:
None
Study First Post Date:
2020-01-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-11-22
Results First Submit QC Date:
None
Results First Post Date:
2024-12-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-22
Last Update Post Date:
2024-12-18
Last Update Post Date Type:
ACTUAL